Summary
0.86 -0.09(-9.47%)10/30/2024
Lyell Immunopharma Inc (LYEL)
Lyell Immunopharma Inc (LYEL)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-9.47 | -15.46 | -31.14 | -39.31 | -57.92 | -47.11 | 0.00 | -94.39 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 0.86 | |
Open | 0.93 | |
High | 0.95 | |
Low | 0.85 | |
Volume | 1,201,805 | |
Change | -0.09 | |
Change % | -9.47 | |
Avg Volume (20 Days) | 1,453,487 | |
Volume/Avg Volume (20 Days) Ratio | 0.83 | |
52 Week Range | 0.86 - 3.26 | |
Price vs 52 Week High | -73.67% | |
Price vs 52 Week Low | -0.20% | |
Range | 7.59 | |
Gap Up/Down | -0.28 |
Fundamentals | ||
Market Capitalization (Mln) | 389 | |
EBIDTA | 0 | |
PE Ratio | 0.0000 | |
PEG Ratio | 0.0000 | |
WallStreet Target Price | 0.00 | |
Book Value | 0.0000 | |
Earnings Per Share | 0.0000 | |
EPS Estimate Current Quarter | 0.0000 | |
EPS Estimate Next Quarter | 0.0000 | |
EPS Estimate Current Year | 0.0000 | |
EPS Estimate Next Year | 0.0000 | |
Diluted EPS (TTM) | 0.0000 | |
Revenues | ||
Profit Marging | 0.0000 | |
Operating Marging (TTM) | 0.0000 | |
Return on asset (TTM) | 0.0000 | |
Return on equity (TTM) | 0.0000 | |
Revenue TTM | 0 | |
Revenue per share TTM | 0.0000 | |
Quarterly Revenue Growth (YOY) | 0.0000 | |
Quarterly Earnings Growth (YOY) | 0.0000 | |
Gross Profit (TTM) | 0 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 0.0000 | |
Forward PE | 0.0000 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 0.0000 | |
Revenue Enterprise Value | 0.0000 | |
EBITDA Enterprise Value | 0.0000 | |
Shares | ||
Shares Outstanding | 0 | |
Shares Float | 0 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.00 | |
Insider (%) | 0.00 | |
Institutions (%) | 0.00 |